FDA 483 OBSERVATION · #873 OF 1,932 MOST-CITED

Equipment calibration frequency

FDA cited this observation 22 times across 22 firms in recent inspections. Below: how it breaks down by program area and fiscal year, and real examples of how FDA worded it on Form FDA 483.

What this grouping is not

An observation-type page groups FDA’s published citation records. The grouping, the compliance steps and the root causes are SPEQ synthesis, not an FDA classification of any citation, and a count measures what FDA published rather than risk.

BY PROGRAM AREA
Biologics22
BY FISCAL YEAR
FY20262
FY20242
FY20223
FY20212
FY20194
FY20181
FY20177
FY20161

How FDA worded it — real examples

Equipment used in the storage and distribution of blood and blood components is not observed, standardized and calibrated with at least the frequency required.

Octapharma Plasma Inc · Mesa, Arizona · Biologics · 2026-05-14

Equipment used in the collection of blood and blood components is not observed, standardized and calibrated with at least the frequency required.

LifeSouth Community Blood Centers Inc · Columbus, Georgia · Biologics · 2026-02-11

Equipment used in the collection, processing and storage and distribution of blood and blood components is not observed, standardized and calibrated with at least the frequency required.

Carter BloodCare - Texoma · Sherman, Texas · Biologics · 2024-08-23

Equipment used in the collection and processing of blood and blood components is not observed, standardized and calibrated with at least the frequency required.

LifeSouth Community Blood Centers, Inc · Gainesville, Georgia · Biologics · 2024-02-07

Equipment used in the processing of blood and blood components is not observed, standardized and calibrated with at least the frequency required.

Innovative Transfusion Medicine, Inc. · Miami Lakes, Florida · Biologics · 2022-06-24

Equipment used in the collection and processing of blood and blood components is not observed, standardized and calibrated with at least the frequency required.

Blood Assurance, Inc. · Columbia, Tennessee · Biologics · 2022-02-14

Related SPEQ references

Where to read the requirements behind this observation area on SPEQ. These are SPEQ's topic and audience pages — not an FDA classification of the citation.

Biologics industry →

Examples are a representative sample of FDA's published inspection observations. Open the 483 observation explorer →